Valuation: Mega Lifesciences

Market Cap 31.91B 942M 856M 791M 714M 1.35B 88.46B 1.4B 9.51B 3.77B 47.47B 3.53B 3.46B 150B P/E 2026 *
13.2x
P/E 2027 * 12.8x
Enterprise Value 27.64B 816M 741M 685M 619M 1.17B 76.63B 1.21B 8.24B 3.26B 41.12B 3.06B 3B 130B EV / Sales 2026 *
1.88x
EV / Sales 2027 * 1.75x
Free-Float
38.66%
Yield 2026 *
5%
Yield 2027 * 5.25%
1 day-0.41%
1 week+3.83%
Current month+10.91%
1 month+10.91%
3 months-3.68%
6 months+4.57%
Current year+9.25%
1 week 34.5
Extreme 34.5
37
1 month 32.5
Extreme 32.5
37
Current year 31.5
Extreme 31.5
40
1 year 30
Extreme 30
40
3 years 24.3
Extreme 24.3
44.25
5 years 24.3
Extreme 24.3
56.5
10 years 17.9
Extreme 17.9
56.5
Manager TitleAgeSince
Chief Executive Officer 64 01/01/1988
Director of Finance/CFO 62 01/01/1997
Chief Operating Officer - -
Director TitleAgeSince
Director/Board Member 62 01/01/1998
Director/Board Member 64 01/01/2013
Director/Board Member 73 01/02/2013
Date Insider Type Main position Quantity % Market Cap. Importance
29/04/25 Buy

Chief Executive Officer

100,000 0.0115%
28/04/25 Buy

Chief Executive Officer

50,000 0.0057%
28/04/25 Buy

Chief Executive Officer

150,000 0.0172%
Change 5-day change 1-year change 3-year change Capi.($)
-0.41%+3.83%+20.00%-11.81% 946M
-0.82%+5.74%+39.64%+143.26% 1,286B
-1.12%+2.29%+44.21%+89.89% 688B
-0.16%+1.11%+26.76%+114.06% 521B
+1.14%+4.87%+43.06%+71.97% 386B
-2.23%-1.55%+55.47%+42.54% 364B
+1.27%+2.01%+30.01%+62.35% 302B
+0.37%+0.75%+3.71%+39.09% 287B
-0.72%+0.41%+37.29%+69.33% 252B
-0.30%+0.41%+34.04%+123.32% 208B
Average -0.30%+0.83%+33.42%+74.40% 430B
Weighted average by Cap. -0.47%+0.84%+36.97%+98.24%

Financials

2026 *2027 *
Net sales 14.74B 435M 395M 365M 330M 623M 40.87B 645M 4.39B 1.74B 21.93B 1.63B 1.6B 69.47B 15.5B 458M 416M 384M 347M 655M 42.97B 678M 4.62B 1.83B 23.06B 1.72B 1.68B 73.04B
Net income 2.39B 70.52M 64.06M 59.19M 53.47M 101M 6.62B 104M 712M 282M 3.55B 265M 259M 11.26B 2.49B 73.57M 66.84M 61.75M 55.78M 105M 6.91B 109M 743M 294M 3.71B 276M 270M 11.74B
Net Debt -4.27B -126M -114M -106M -95.49M -180M -11.83B -187M -1.27B -504M -6.35B -473M -463M -20.1B -4.73B -140M -127M -117M -106M -200M -13.11B -207M -1.41B -559M -7.04B -524M -513M -22.29B
Projected Income Statement - Annual - Mega Lifesciences
Logo Mega Lifesciences
Mega Lifesciences Public Company Limited is a Thailand-based company, which is engaged in health and wellness industry. Its segments include Brands, Distribution and OEM. MEGA We Care is its branded products business, through which it develops, manufactures, markets and sells its own range of nutraceuticals, complementary medicines, prescription pharmaceuticals and over the counter (OTC) health products. Maxxcare serves as its prominent distribution arm, specializing in the marketing, sales, and distribution of a range of branded prescription pharmaceuticals, OTC medications and fast-moving consumer goods (FMCG) across key markets such as Myanmar, Vietnam and Cambodia. Its suite of services encompasses warehouse management, collections and value-added initiatives, including tailored marketing services for principals in the pharmaceutical and FMCG sectors. Its manufacturing facilities in Thailand, Australia and Indonesia also accept production orders from various third-party customers.
Employees
-
Date Price Change Volume
16/11/26 THB 36.60 -0.41% 1,385,270
13/11/26 THB 36.75 +4.26% 2,068,163
12/11/26 THB 35.25 -0.70% 257,154
11/11/26 THB 35.50 0.00% 734,250
10/11/26 THB 35.50 0.00% 1,639,355
Trader
Investor
Global
Quality
ESG MSCI
A
MarketScreener Ratings - Mega Lifesciences
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
36.60THB
Average target price
42.83THB
Spread / Average Target
+17.02%
  1. Stock Market
  2. Stocks
  3. MEGA Stock